cbdMD
YCBD
6 hedge funds and large institutions have $174K invested in cbdMD in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
200% more funds holding
Funds holding: 2 → 6 (+4)
135% more capital invested
Capital invested by funds: $74K → $174K (+$100K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$57.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$49.3K |
| 3 |
Morgan Stanley
New York
|
+$49.3K |
| 4 |
VF
Virtu Financial
New York
|
+$47.6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$4.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$71K |
YCBD Hedge Fund Activity: Q2 2018 in Review
6 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q2 2018, worth a combined $174K — up 135% from $74K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new YCBD positions and 1 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $57.5K. The largest seller was Millennium Management, exiting entirely with an estimated $71K sold.
- 6 institutional investors held cbdMD (YCBD) as of Q2 2018, up from 2 in Q1 2018.
- Funds reported $174K of cbdMD stock for Q2 2018, up 135% quarter-over-quarter.
- 5 funds opened new cbdMD positions in Q2 2018 and 1 closed out, a net change of +4 holders.
- The largest cbdMD buyer in Q2 2018 was BlackRock, an estimated $57.5K added.
- The largest cbdMD seller in Q2 2018 was Millennium Management, an estimated $71K sold.
Based on aggregated 13F filings for Q2 2018.